Storage of Transfusion Platelet Concentrates Is Associated with Complement Activation and Reduced Ability of Platelets to Respond to Protease-Activated Receptor-1 and Thromboxane A2 Receptor.

complement activation hemostasis platelet function platelet storage platelet storage lesion

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
16 Jan 2024
Historique:
received: 18 12 2023
revised: 05 01 2024
accepted: 12 01 2024
medline: 23 1 2024
pubmed: 23 1 2024
entrez: 23 1 2024
Statut: epublish

Résumé

Platelet activation and the complement system are mutually dependent. Here, we investigated the effects of storage time on complement activation and platelet function in routinely produced platelet concentrates. The platelet concentrates (n = 10) were stored at 22 °C for seven days and assessed daily for complement and platelet activation markers. Additionally, platelet function was analyzed in terms of their responsiveness to protease-activated receptor-1 (PAR-1) and thromboxane A2 receptor (TXA

Identifiants

pubmed: 38256162
pii: ijms25021091
doi: 10.3390/ijms25021091
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Swedish Research Council
ID : 2018-04087
Organisme : Crafoord Foundation
ID : 20210961
Organisme : Health Research Council in the South East of Sweden
ID : 940971 and 969250

Auteurs

Linnea I Andersson (LI)

Department of Chemistry and Biomedicine, Linnaeus University, 391 82 Kalmar, Sweden.

Dick J Sjöström (DJ)

Department of Chemistry and Biomedicine, Linnaeus University, 391 82 Kalmar, Sweden.

Huy Quang Quach (HQ)

Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN 55905, USA.

Kim Hägerström (K)

Department of Clinical Chemistry and Transfusion Medicine, Region Kalmar County, 391 85 Kalmar, Sweden.

Lisa Hurler (L)

Department of Internal Medicine and Haematology, Semmelweis University, 1088 Budapest, Hungary.

Erika Kajdácsi (E)

Department of Internal Medicine and Haematology, Semmelweis University, 1088 Budapest, Hungary.

László Cervenak (L)

Department of Internal Medicine and Haematology, Semmelweis University, 1088 Budapest, Hungary.

Zoltán Prohászka (Z)

Department of Internal Medicine and Haematology, Semmelweis University, 1088 Budapest, Hungary.

Erik J M Toonen (EJM)

R&D Department, Hycult Biotechnology, 5405 Uden, The Netherlands.

Camilla Mohlin (C)

Department of Chemistry and Biomedicine, Linnaeus University, 391 82 Kalmar, Sweden.

Tom Eirik Mollnes (TE)

Department of Immunology, Oslo University Hospital, University of Oslo, 0372 Oslo, Norway.
Research Laboratory, Nordland Hospital, 8005 Bodo, Norway.

Per Sandgren (P)

Center for Hematology and Regenerative Medicine (HERM), Karolinska Institutet, 171 77 Huddinge, Sweden.

Ivar Tjernberg (I)

Department of Clinical Chemistry and Transfusion Medicine, Region Kalmar County, 391 85 Kalmar, Sweden.
Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Linköping University, 581 83 Linköping, Sweden.

Per H Nilsson (PH)

Department of Chemistry and Biomedicine, Linnaeus University, 391 82 Kalmar, Sweden.
Linnaeus Centre for Biomaterials Chemistry, Linnaeus University, 391 82 Kalmar, Sweden.

Classifications MeSH